Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>DDERMMAL</i>, a melanocytic long non-coding RNA, confers DNA damage tolerance to melanoma cells.

iScience·2026

Same author

AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.

Cell death discovery·2026

Same author

Association of tumour-associated macrophage states with nonconserved lncRNAs in lung cancer.

Genes and immunity·2026

Same author

The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity.

The Journal of experimental medicine·2025

Same author

Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State.

Cancer research·2025

Same author

Single-cell genome and transcriptome sequencing without upfront whole-genome amplification reveals cell state plasticity of melanoma subclones.

Nucleic acids research·2025

Search research articles

Related Experiment Video

Updated: Jun 29, 2025

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Humanized mouse models for anti-cancer therapy.

Maria Francesca Baietti¹, Eleonora Leucci¹

¹TRACE PDX Platform, LKI Leuven Cancer Institute, Leuven, Belgium; Laboratory of RNA Cancer Biology, Department of Oncology, LKI Leuven Cancer Institute, Leuven, Belgium.

Methods in Cell Biology

|March 28, 2024

Summary

Patient-derived xenograft (PDX) models are crucial for cancer research. This study details methods for creating humanized PDX models to test novel immune oncology drugs and therapies.

Keywords:

Humanization Immunotherapy In vivo PDX Tumor models Xenografts

More Related Videos

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Related Experiment Videos

Last Updated: Jun 29, 2025

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Area of Science:

Oncology
Immunology
Preclinical Research

Background:

Patient-derived xenograft (PDX) models are essential preclinical tools that mimic human tumor complexity.
Traditional PDX models use immunocompromised animals, limiting their utility for evaluating immunotherapies.
The rise of immune oncology necessitates advanced models for drug testing.

Purpose of the Study:

To describe detailed methodologies for establishing humanized PDX models.
To enable effective preclinical testing of immune oncology drugs and combination therapies.
To advance the development of personalized anti-cancer therapeutic strategies.

Main Methods:

Detailed protocols for generating humanized PDX models are presented.
Methods focus on engrafting human immune components into PDX models.
Standardized procedures for anti-cancer therapy testing within these models are outlined.

Main Results:

Humanized PDX models were successfully established.
These models demonstrated the potential for evaluating immune oncology drugs.
The described methods provide a reproducible approach for generating humanized PDX models.

Conclusions:

Humanized PDX models are critical for advancing immune oncology drug development.
The detailed methods facilitate the creation of these advanced preclinical models.
This work supports the evaluation of novel anti-cancer therapies in a human-relevant context.